St. Luke's Center for Gastroenterology Research
Bringing New Advances in Patient Care
The St. Luke's Center for Gastroenterology Research leads research programs in interventional gastroenterology, chronic inflammatory disease, and early diagnosis and treatment of gastrointestinal tumors. The Center also researches use of screening tools for disease prevention, surveillance of pre-cancerous conditions, biorepository and tissue banking to study the patho-physiology of gastrointestinal illness, novel imaging techniques, and multi-disciplinary collaboration to improve quality-of-life and health care outcomes, among others.
The mission of the St. Luke's Center for Gastroenterology Researchis to conduct clinical and basic research on core areas of the gut to develop interventions to prevent or treat gastroenterological Illness and diseases at various stages. The focus of the center is to study the role of newer technologies in minimally invasive, endoscopic treatment of gastrointestinal illness by avoiding major surgery. The long-term goal of the center is to find etiologies of certain diseases so that burden of disease on individual patient and health care resources is minimized, and more importantly, improve individual outcomes by application of biomedical research. Projects are supported by funding from the National Institutes of Health, Aurora Health Care Foundation and industry leaders.
Nalini Guda, MD, is the director for St. Luke's Center for Gastroenterology Research, and a clinical associate professor of medicine at the University of Wisconsin School of Public Health and Medicine. Dr. Guda works with other like-minded colleagues in gastroenterology and also with the gastroenterology fellows. He works closely with his colleagues in other subspecialties to collaborate on key clinical studies.
The team works closely with academic centers and the community to provide opportunities for health care providers and the public to advance awareness about prevention of GI Illness and also aid in early prevention of certain key gastrointestinal cancers.